DURHAM, N.C., October 9, 2016 — Premier Research’s quality assurance chief will chair a session at the Research Quality Association’s 2016 Annual Conference in Brighton, U.K. Nicky Dodsworth, Vice President of Global Quality Assurance, will lead the session taking place Thursday, November 10, starting at 9 a.m. Stream C, Session 1 at the RQA conference...
DURHAM, N.C., October 28, 2016 — STARR Coalition, an organization dedicated to treatment, advocacy, research, and recovery in mental health, named Premier Research CRO of the Year at its annual STARR Meeting in Boca Raton, Florida. The group cited Premier Research for its longstanding partnership in supporting the coalition’s mission to serve the mental health...
DURHAM, N.C., OCTOBER 27, 2016 — Medical device and diagnostic companies are conducting more clinical trials than ever, a trend that’s giving rise to new procedures and best practices for studies that differ in many ways from pharmaceutical trials. Register for this webinar focused on the evolution of device clinical research on Wednesday, November 2....
DURHAM, N.C., October 26, 2016 — Premier Research’s lead strategist will participate in a panel discussion on the evolving landscape for investigator sites at CNS Summit 2016 in Boca Raton, Florida. Krista Armstrong, Vice President of Strategic Development, will join colleagues in addressing topics such as: Advantages and disadvantages of site consolidation Site selection and strategic...
Investment Will Advance Premier’s Next Development Phase RESEARCH TRIANGLE PARK, N.C., Oct. 17, 2016 — Premier Research (“Premier” or the “Company”), a leading middle-market contract research organization (“CRO”) that provides comprehensive clinical development, analytic, and support services to pharmaceutical, biotech, and medical device customers worldwide, today announced that it will receive a growth investment from...
DURHAM, N.C., OCTOBER 3, 2016 — You’re starting a lengthy project that’s fraught with risk and could cost a billion dollars or more to complete. A couple of early missteps might spell disaster. Welcome to clinical drug research. Boost your odds of success with a robust project schedule and carefully executed startup plan. At MAGI’s...
DURHAM, N.C., SEPTEMBER 29, 2016 — Point-in-time “landmark” analysis, the standard in most chronic pain studies, may not be appropriate for evaluating single-dose drugs. Instead, an analysis strategy similar to that used in acute-pain research may be more effective, Premier Research’s top biostatistics expert will assert in a poster presentation at the American Statistical Association’s...
DURHAM, N.C., August 10, 2016 — Patient advocacy groups play an important and growing role in developing drugs to treat cancer and rare diseases, contributing to study design, recruiting patients, and even directly funding clinical trials. At a September webinar, Premier Research will team with rare disease advocacy organization Global Genes to explore this important...
DURHAM, N.C., August 08, 2016 — It’s one of the most important things to get right in any clinical trial, yet almost nobody does it well. Trial forecasting requires constant pursuit of fast-moving targets, but most efforts are hobbled by manual processes that are slow and ineffective — and it only gets tougher as studies...
DURHAM, N.C., June 27, 2016 — Small biotechnology companies taking new biopharmaceutical products from benchtop to bedside need an informed regulatory strategy and a close working knowledge of the Food and Drug Administration and other regulatory agencies. So when it sought a new head of regulatory affairs, clinical development service provider Premier Research found its ideal...